AKTX

Akari Therapeutics
AKTX

Overview Fund Activity

12 hedge funds and large institutions have $1.84M invested in Akari Therapeutics in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
-3
Holders Change %
-20%
% of All Funds
0.19%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
3
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SM
Sabby Management
Florida
+$776K
2
Renaissance Technologies
Renaissance Technologies
New York
+$41.8K
3
Millennium Management
Millennium Management
New York
+$37.1K

Top Sellers

1
AC
Armistice Capital
New York
-$1.63M
2
Citadel Advisors
Citadel Advisors
Florida
-$7.57K
3
TSS
Two Sigma Securities
New York
-$6.31K
4
VF
Virtu Financial
New York
-$5K
Name Holding Trade Value Shares
Change 		Shares
Change %
SM
1
Sabby Management
Florida
$1.44M +$776K +213,676 +116%
OFW
2
Omnia Family Wealth
Florida
$142K – – –
NMC
3
NEA Management Company
Maryland
$82.2K – – –
Renaissance Technologies
4
Renaissance Technologies
New York
$52K +$41.8K +11,405 +411%
Millennium Management
5
Millennium Management
New York
$47K +$37.1K +10,306 +374%
LPL Financial
6
LPL Financial
California
$24.4K – – –
HP
7
Hikari Power
Japan
$24K – – –
BMCM
8
Bryn Mawr Capital Management
Pennsylvania
$18.2K – – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$5.5K – – –
Bank of America
10
Bank of America
North Carolina
$543 – – –
TC
11
Truvestments Capital
Florida
$183 – – –
AC
12
Armistice Capital
New York
– -$1.63M -173,500 Closed
Citadel Advisors
13
Citadel Advisors
Florida
– -$7.57K -772 Closed
TSS
14
Two Sigma Securities
New York
– -$6.31K -671 Closed
VF
15
Virtu Financial
New York
– -$5K -525 Closed